Why Breast Cancer Awareness Must Include Cannabis Conversations

Every October, Breast Cancer Awareness Month sparks a national conversation about early detection, research funding and survivorship. It’s a vital moment to honor those affected by this disease and amplify the resources available to them. But one piece of the symptom management framework remains largely absent from the mainstream dialogue: medical cannabis.

As a supportive oncologist, researcher, and Chief Medical Consultant at Ethos Cannabis, I see firsthand how cannabis supports patients. Not as a cure, but as a tool for symptom relief, quality of life improvements, empowerment throughout survivorship and beyond. It’s time we brought this conversation into the light.

Symptom Relief Backed by Evidence

Nausea, loss of appetite, insomnia, anxiety, pain. These are some daily realities for many people undergoing treatment for breast cancer. While conventional therapies exist, not all patients tolerate them well. This is where cannabis, when used appropriately and under medical guidance, serves as a supportive option.

Clinical studies and anecdotal experiences alike point to cannabis’ potential in easing chemotherapy-induced nausea, improving sleep and managing chronic pain, all without the high addiction risk associated with opioids. Through my work at Thomas Jefferson University and in partnership with Ethos Cannabis, we continue to explore how cannabis can be integrated safely into cancer care, with a focus on personalized, research-backed guidance.

Survivorship Deserves Holistic Support

Cancer doesn’t end when treatment stops. Survivors often grapple with fatigue, joint pain, emotional trauma and hormonal symptoms, to name a few. Yet the post-treatment phase is where supportive care options become sparse.

Cannabis offers a bridge, a wellness tool that promotes rest, reduces discomfort and empowers individuals to regain a sense of control in their lives. This starts with education, not assumptions. Every patient deserves access to evidence-informed conversations about cannabis, without fear of judgment or stigma.

Destigmatizing for Equity

Despite growing public acceptance, cannabis continues carrying outdated stigmas, especially among older adults, BIPOC communities and those from conservative or underserved backgrounds. Many patients who could benefit the most are also the least likely to receive credible information from their providers. That’s a failure of the system, not of the patient.

Ethos Cannabis uses an education-first approach grounded in breaking down these barriers. Our “Colas for a Cure” initiative raised funds for Living Beyond Breast Cancer and helped advance the conversation around cannabis as a therapeutic resource for women navigating breast cancer.

It’s simply not enough to make cannabis accessible. We must also make it understandable, trustworthy, and inclusive.

The Path Forward: Clinical Integration

To responsibly include cannabis in oncology care, we need three things:

1. Robust research on product efficacy and safety
2. Medical training to empower clinicians to discuss cannabis confidently
3. Policy changes that expand access, reduce stigma, and protect patient rights

In partnership with Thomas Jefferson University, we’re building this foundation. Our work at Ethos focuses on developing products and educational tools that serve patients, not trends.

I’m optimistic, but also realistic. True integration of cannabis into cancer care will take time. It will take continued advocacy and education. And it will take courageous, patient-first conversations, especially during moments like Breast Cancer Awareness Month.

If we want to honor those affected by breast cancer, not just in October but year-round, we need to expand the toolkit of care. For many patients, cannabis is not an alternative. It’s an
essential complement to their healing journey.